Evidence map›Paper›PMID 19546172›Full record

ArticleGenome research2009

Epigenetics of human T cells during the G0-->G1 transition.

Alexander E Smith, Constantinos Chronis, Manolis Christodoulakis, Stephen J Orr, Nicholas C Lea, Natalie A Twine, Akshay Bhinge, Ghulam J Mufti, N Shaun B Thomas

Open access · bronzeAbstract read
In one paragraph

Article in Genome research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Asymmetric cancer cell division regulated by AKT.Proceedings of the National Academy of Sciences of the United States of America · 2011
    Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Alexander E SmithKing's College London, Department of Haematological Medicine, Leukaemia Sciences Laboratories, Rayne Institute, London, United Kingdom.
Constantinos Chronis
Manolis Christodoulakis
Stephen J Orr
Nicholas C Lea
Natalie A Twine
Akshay Bhinge
Ghulam J Mufti
N Shaun B Thomas
King's College London · GBThe University of Texas at Austin · USUniversity of East London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We investigated functional epigenetic changes that occur in primary human T lymphocytes during entry into the cell cycle and mapped these at the single-nucleosome level by ChIP-chip on tiling arrays for chromosomes 1 and 6. We show that nucleosome loss and flanking active histone marks define active transcriptional start sites (TSSs). Moreover, these signatures are already set at many inducible genes in quiescent cells prior to cell stimulation. In contrast, there is a dearth of the inactive histone mark H3K9me3 at the TSS, and under-representation of H3K9me2 and H3K9me3 defines the body of active genes. At the DNA level, cytosine methylation (meC) is enriched for nucleosomes that remain at the TSS, whereas in general there is a dearth of meC at TSSs. Furthermore, a drop in meC also marks 3' transcription termination, and a peak of meC occurs at stop codons. This mimics the 3' nucleosomal distribution in yeast, which we show does not occur in human T cells.

Indexed as

Epigenesis, GeneticCells, CulturedChromatin ImmunoprecipitationCpG IslandsDNA MethylationG1 PhaseGene Expression ProfilingGenome-Wide Association StudyHistonesHumansLysineMethylationNucleosomesPromoter Regions, GeneticProtein BindingResting Phase, Cell CycleHistonesLysineNucleosomes

Identifiers

PMID19546172
PMCPMC2720178
OpenAlexW2045646459

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.